SYN 020

Drug Profile

SYN 020

Alternative Names: Oral intestinal alkaline phosphatase - Synthetic Biologics; SYN-020

Latest Information Update: 20 Jun 2016

$50 / €47 *
* $ price applies to USA, Canada and Latin America. € price applies to the rest of the world. Final gross prices may vary according to local VAT.

At a glance

  • Originator Synthetic Biologics
  • Class Phosphoric monoester hydrolases
  • Mechanism of Action Enzyme replacements
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Research Coeliac disease; Inflammatory bowel diseases; Metabolic syndrome

Most Recent Events

  • 10 Mar 2016 Early research in Coeliac disease in USA (PO)
  • 10 Mar 2016 Early research in Inflammatory bowel disease in USA (PO)
  • 10 Mar 2016 Early research in Metabolic syndrome in USA (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top